Subtle Medical Expands in Latin America: SubtleHD™ Now Commercially Available in Chile, Distributed by Hospiline
MENLO PARK, Calif., May 29, 2025 /PRNewswire/ -- Subtle Medical, a global leader in AI-powered medical imaging software, announced today the commercial availability of SubtleHD™ in Chile, marking an important step in expanding access to advanced imaging solutions across Latin America. The company also confirmed it will partner with Hospiline, a trusted regional distributor that currently supports Subtle Medical's growth in Brazil.
SubtleHD™ is an FDA-cleared and CE-marked deep learning technology that transforms the quality of MRI images and enables up to 80% time savings on some sequences. It integrates seamlessly into existing clinical workflows, extending the life and performance of existing MRI scanners, an especially critical need across Latin America, where aging imaging infrastructure is common.
In Brazil, for example, over 66% of MRI scanners are more than six years old, while demand for MRI exams is growing rapidly, estimated at 30,000 scans per million inhabitants per year. As patient volumes rise, public institutions often face long wait times, and many providers are challenged to meet demand with outdated equipment.
SubtleHD helps imaging providers unlock new scan slots without purchasing new hardware, improving operational efficiency and patient throughput. With SubtleHD, healthcare institutions in Chile can now benefit from:
Improved image quality even on older MRI systems
Faster exam times, helping reduce patient backlog
Vendor-neutral compatibility with existing infrastructure
"We're thrilled to expand access to SubtleHD in Chile," said Josh Gurewitz, Chief Commercial Officer, at Subtle Medical. "With the support of Hospiline, imaging providers across the region can now harness AI to overcome infrastructure gaps, boost productivity, and elevate diagnostic confidence."
About Subtle Medical
Subtle Medical is a leading provider of AI-powered imaging solutions, optimizing scan efficiency and image quality across radiology. Recognized as a CB Insights GenAI 50 company and a two-time CB Insights Top AI 100 and Digital Health 150 company, Subtle Medical is committed to driving innovation in medical imaging. Deployed globally across 900+ scanners worldwide, Subtle Medical's solutions help imaging centers and hospitals improve workflow efficiency, increase scanner sustainability, and elevate patient care. Learn more and request a demo at www.subtlemedical.com.
About Hospiline
Hospiline is a trusted distributor of advanced medical technologies across Latin America, committed to delivering innovative solutions that elevate patient care and clinical performance. United by a vision of excellence, we partner with leading global healthcare innovators to bring the most modern, effective technologies to hospitals, clinics, and imaging centers throughout the region. Our mission is to support and optimize the healthcare ecosystem by ensuring access to cutting-edge medical products that enhance outcomes and drive operational efficiency.
Media ContactAnna Menyhart-BorroniHead of Marketinganna@subtlemedical.com
Source:TheGlobalEconomy.comSciELO BrazilUMass Medical School eScholarship
SOURCE Subtle Medical, Inc.
Fehler beim Abrufen der Daten
Melden Sie sich an, um Ihr Portfolio aufzurufen.
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
30 minutes ago
- Hamilton Spectator
‘I appreciate everyone': Community rallies after husband and father's terminal diagnosis
FORT ST. JOHN, B.C. — A Fort St. John woman is applauding the support of the community in the face of her family's heartbreak. Britany Gould and her husband, Tony Lloyd, have been together for 11 years and share two children. Gould told that Lloyd, an oil and gas industry worker, began 'experiencing headaches' and 'forgetting things' in late March, but at the time the couple didn't think much of the situation. 'He started saying that he had really bad neck pain,' said Gould. 'He thought that his neck was [just] out and he needed to go to the chiropractor. 'Then, late at night-time, he started actually getting sick and getting really confused and not knowing what's going on. His balance was quite off. So I ended up having to call the ambulance.' Rushed to Fort St. John Hospital, an MRI scan revealed the grim prognosis: glioblastoma, a fast-growing brain tumour. Lloyd was airlifted to hospital in Vancouver, where the couple spent three weeks. While surgery was performed, only 'a small portion' of Lloyd's tumour could be removed. 'The brain is such a sensitive area and a lot of it was intertwined,' explained Gould. 'It wasn't just sitting on top that they could just kind of pop it off. [The doctors] did say there was a possibility for him to get chemo and radiation down the line.' After spending three weeks in the hospital, Lloyd and Gould flew back to Fort St. John to be closer to home. Unfortunately, further tests revealed the brain tumour had grown, and as a result, Lloyd has lost his eyesight. Doctors in Prince George revealed chemo and radiation therapy was not an option. 'I'm in the hospital with him six to eight hours a day, every single day,' said Gould. 'It's hard thinking about what he's going through and what he's experiencing.' Gould started a GoFundMe campaign in May hoping to raise $5,500, and it has already reached $4,525. Local businesses have stepped up and raised funds to assist the family. Local food vendor Lucas's Pit Stop has raised money via a jar at events at the Northern Lights Raceway. Its last event catered by the establishment raised $1,200. In addition, Audielicious in Fort St. John began a burger drive on May 29th, with $5 dollars from every burger sold going toward the family until June 8th. Gould and owner Audie Louie worked together at Charlie Lake's former Jackfish Dundee Pub in the past and are close friends. 'Everyone's been so sweet. It actually takes a bit of a burden off my shoulders, especially for a little while,' said Gould. 'I can take care of Tony, I can take care of the kids. I really want to spend as much time with them, just give them all the attention that they need and deserve. 'Everyone's just been amazing beyond words. I appreciate everyone.' To donate to the GoFundMe campaign, visit its website . Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .
Yahoo
34 minutes ago
- Yahoo
Why Guardant Health Stock Surged Nearly 9% Higher Today
The company's Shield multi-cancer detection test won an important designation from a top regulator. This should help bring it to market quicker. 10 stocks we like better than Guardant Health › Precision oncology specialist Guardant Health (NASDAQ: GH) was something of a stock market star on Tuesday. On the back of very positive news in the regulatory sphere, the company's shares jumped almost 9% higher today. This made it quite the outperformer on the exchange, as the bellwether S&P 500 index's gain was a relatively modest 0.6%. This morning before market open, Guardant announced that the U.S. Food and Drug Administration (FDA) had granted the healthcare company's Shield multi-cancer detection (MCD) test its Breakthrough Device designation. This instantly confers a high status on Shield, as the FDA's designation is given only to a small clutch of medical devices that can either diagnose or treat a disease more effectively than other products. In Shield's case, it is quite a versatile diagnostic device that can screen for a wide range of cancers, including colorectal, lung, and ovarian. It is designed to evaluate people 45 years of age or older who are at a typical average risk for cancer. According to Guardant, Shield has 98.6% specificity and 75% sensitivity in detecting certain cancers. In its news release touting the FDA's move, Guardant quoted its co-CEO AmirAli Talasaz as saying that it "shows the promise of the Shield MCD test to detect multiple cancers at an early stage with just a single, routine blood draw." "We look forward to partnering with the agency and other stakeholders to bring this breakthrough to patients quickly," he added. Another big plus of the Breakthrough Device designation is that it's part of an FDA initiative aimed at getting useful medical products to market faster. Talasaz and his team at Guardant might just get their wish with Shield before long. Before you buy stock in Guardant Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Guardant Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,385!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $842,015!* Now, it's worth noting Stock Advisor's total average return is 987% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Guardant Health. The Motley Fool has a disclosure policy. Why Guardant Health Stock Surged Nearly 9% Higher Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Los Angeles Times
42 minutes ago
- Los Angeles Times
Red Light, Real Results? These Red Light Face Masks Actually Work
LA Times Studios may earn commission from purchases made through our links. Your coworker's face is glowing red on Zoom, not metaphorically. Your dermatologist's waiting room looks like a futuristic spa. And on TikTok, 20-somethings and 50-somethings alike are strapping LED-lit shields to their faces like they're prepping for battle. The question we're all asking, though, is whether red light face masks actually work? Or are they just vibey headlamps for your face? Let's flip on the facts. Red light therapy (RLT) uses low-wavelength red and near-infrared light to penetrate the skin at a cellular level. It's not magic, but the mechanism behind it might as well be: wavelengths between 630–850 nanometers stimulate your mitochondria (yes, the powerhouse of the cell) to produce more ATP, your cells' energy currency. Translation? More energy for your skin to repair, regenerate, and radiate. A review in Seminars in Cutaneous Medicine and Surgery concluded that red and near-infrared light 'can stimulate collagen production, enhance fibroblast proliferation, and accelerate wound healing.' Another clinical study found that consistent red light use measurably improved wrinkles, tone, and firmness in just 12 weeks. Light therapy isn't new, it's been studied for decades. What researchers found is that light in a narrow band of red and near-infrared wavelengths can safely stimulate health benefits by acting directly on the mitochondria in your cells. According to red light tech company Joylux, 'It is believed that mitochondria, in their excited state, release ATP (adenosine triphosphate) and NO (Nitric Oxide). Increased ATP means more energy to build collagen and repair tissue. Increased NO means improved blood flow, which helps the necessary nutrients and oxygen travel throughout our body.' So yes, the glow is real and cellular. Though most people grab a red light mask to battle fine lines or acne, the benefits go deeper. 'Red light stimulates cellular repair, increases blood circulation, enhances collagen production, supports tissue regeneration, and improves natural hydration,' according to Joylux. In fact, red light therapy is now being explored not only for facial skin health but for broader concerns like wound healing, pain relief, hair growth, and intimate wellness. It's showing promise in addressing issues related to menopause, inflammation, and even muscle recovery. Not all LED masks are created equal. Some are scientifically sound; others are overpriced plastic cosplay. Here's the glow-down on the best red light masks right now: Best for: Collagen and elasticityMade famous by Emily in Paris, and even more by real dermatologists, uses dual wavelengths (633nm red + 830nm near-infrared) to boost collagen and reduce wrinkles. It's flexible, FDA-cleared, and has solid independent clinical backing.💸 $379 at CurrentBody Best for: Acne + anti-aging multitaskersWith 100 red and 62 blue LEDs, this celebrity-endorsed mask tackles breakouts and fine lines in one go. A staple in both luxury skincare clinics and influencer vanities.💸 $455 at Revolve Best for: Beauty minimalists and budget-conscious glow-gettersSkin Gym's Pro LED Mask delivers serious results with a luxe design that wouldn't look out of place at an aesthetician's studio. Featuring red, blue, green, yellow, and purple light modes, this device targets everything from fine lines to breakouts and dullness.💸 $299 at SkinGym Best for: Sensitive skin and rosaceaGentle, flexible, and FDA-cleared, this mask is often recommended by dermatologists for calming inflammation and boosting elasticity. A true derm-favorite for delicate skin.💸 $395 at Omnilux Best for: Targeted wrinkle reduction and enhanced skin radianceThe Solawave Wrinkle Retreat Light Therapy Face Mask is an FDA-cleared device that combines red and near-infrared light therapy to address signs of aging. Crafted from flexible, medical-grade silicone, it comfortably conforms to the face, delivering a hands-free, 10-minute treatment designed to reduce fine lines, wrinkles, and discoloration. 💸 $349 at Ulta If you're expecting overnight miracles, you'll be disappointed. But if you're down for the long game (think 3–5 sessions a week, for 6–12 weeks), the science says yes. According to a 2023 analysis in Lasers in Medical Science, red light therapy is 'statistically significant in reducing wrinkle depth and improving skin tone across all skin types.' That said, cheaper knockoffs on Amazon with vague 'LED' claims and no mention of wavelength specifics? Skip them. This isn't just hype. With growing clinical evidence, FDA clearances, and serious investment from brands, red light therapy is poised to become as standard as retinol in your skincare routine. And in a world where beauty intersects with recovery, stress relief, and biohacking, it's hitting the sweet spot of science and self-care. Click here to learn more about Joylux
